Fizazi K - Search Results

1

[New drugs in metastatic castration-resistant prostate cancer].

Albiges L, Loriot Y, Gross-Goupil M, de La Motte Rouge T, Blesius A, Escudier B, Massard C, Fizazi K. Albiges L, et al. Among authors: fizazi k. Bull Cancer. 2010 Jan;97(1):149-59. doi: 10.1684/bdc.2009.1023. Bull Cancer. 2010. PMID: 20022854 French.

2

[Soft tissue sarcomas: general review].

Fizazi K, Cojean I, Le Cesne A, Kayitalire L, Le Chevalier T, Tursz T, Spielmann M. Fizazi K, et al. Bull Cancer. 1994 Oct;81(10):835-52. Bull Cancer. 1994. PMID: 7734766 Review. French.

3

[Inappropriate antidiuretic hormone secretion disclosing a second primary lung cancer 5 years after complete remission of a small cell lung carcinoma].

Soria JC, Fizazi K, Merad M, Le Chevalier T. Soria JC, et al. Among authors: fizazi k. Bull Cancer. 1996 Aug;83(8):605-8. Bull Cancer. 1996. PMID: 8869039 French.

4

[Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology].

Fizazi K, Culine S, Droz JP, Le Chevalier T, Ruffié P, Théodore C. Fizazi K, et al. Bull Cancer. 1997 Mar;84(3):313-27. Bull Cancer. 1997. PMID: 9207879 Review. French.

5

[Metastatic carcinoma of unknown origin].

Fizazi K, Culine S. Fizazi K, et al. Bull Cancer. 1998 Jul;85(7):609-17. Bull Cancer. 1998. PMID: 9752267 Free article. Review. French.

6

Combination interleukin-2 and doxorubicin in advanced adult solid tumors: circumvention of doxorubicin resistance in soft-tissue sarcoma?

Le Cesne A, Vassal G, Farace F, Spielmann M, Le Chevalier T, Angevin E, Valteau-Couanet D, Fizazi K, Cojean I, Llombard A, Tursz T, Escudier B. Le Cesne A, et al. Among authors: fizazi k. J Immunother. 1999 May;22(3):268-77. doi: 10.1097/00002371-199905000-00010. J Immunother. 1999. PMID: 10335487 Clinical Trial.

7

[Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer].

Ducreux M, Fizazi K, Seitz JF, Becouarn Y, Armand JP. Ducreux M, et al. Among authors: fizazi k. Bull Cancer. 2001 Aug;88 Spec No:S35-9. Bull Cancer. 2001. PMID: 11567912 Review. French.

8

A 10-year clinical experience with intermittent hormonal therapy for prostate cancer.

Prapotnich D, Fizazi K, Escudier B, Mombet A, Cathala N, Vallancien G. Prapotnich D, et al. Among authors: fizazi k. Eur Urol. 2003 Mar;43(3):233-39; discussion 239-40. doi: 10.1016/s0302-2838(03)00004-6. Eur Urol. 2003. PMID: 12600425

9

A phase II study of irinotecan in patients with advanced renal cell carcinoma.

Fizazi K, Rolland F, Chevreau C, Droz JP, Mery-Mignard D, Culine S, Escudier B. Fizazi K, et al. Cancer. 2003 Jul 1;98(1):61-5. doi: 10.1002/cncr.11474. Cancer. 2003. PMID: 12833456 Free article. Clinical Trial.

10

Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.

Gholam D, Fizazi K, Terrier-Lacombe MJ, Jan P, Culine S, Theodore C. Gholam D, et al. Among authors: fizazi k. Cancer. 2003 Aug 15;98(4):745-52. doi: 10.1002/cncr.11574. Cancer. 2003. PMID: 12910518 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters